Adaptin Bio (APTN) Payables (2022 - 2026)

Adaptin Bio has disclosed Payables across 5 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Payables rose 151.14% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $1.7 million (up 151.14% YoY), while the FY2025 annual figure was $1.5 million, down 20.67% from the prior year.
• Payables came in at $1.7 million for Q2 2026 at Adaptin Bio, up from $1.4 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.9 million in Q4 2024 to a low of $12804.0 in Q4 2022.
• Average Payables over 5 years is $725475.2, with a median of $327057.0 recorded in 2025.
• Year-over-year, Payables soared 2245.11% in 2024 and decreased 20.67% in 2025.
• Over 5 years, Payables stood at $12804.0 in 2022, then jumped by 534.78% to $81277.0 in 2023, then soared by 2245.11% to $1.9 million in 2024, then retreated by 20.67% to $1.5 million in 2025, then increased by 10.71% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.7 million in Q2 2026, $1.4 million in Q1 2026, and $1.5 million in Q4 2025.